In direct response to Vice President Biden’s Cancer Moonshot, Atlanta-based Global Center for Medical Innovation (GCMI) and T3 Labs are...
About IMAT
The Innovative Molecular Analysis Technologies (IMAT) program was established to support the development, technical maturation, and dissemination of novel and potentially transformative next-generation technologies through an approach of balanced but targeted innovation. In support of its mission, the IMAT program utilizes a variety of investigator-initiated research project grant mechanisms while retaining a strong commitment to diversity and to the training of scientists and clinicians in cross-cutting, research-enabling disciplines.
Please select a link below to learn more about IMAT.
Recent News & Upcoming Events
IMAT and ITCR launching a new effort to catalyze collaborations across the two programs. Contact Tony Dickherber for details.
An extensive impact assessment of the IMAT program was recently completed by a professional evaluation firm (Ripple Effect Communications, Inc). NCI is thankful to all...
All small business innovation research (SBIR) and small business technology transfer (STTR) applications have been administratively consolidated under the administration of the...